2m 2m 2m 2m 2m 2m 2m
ARCUS BIOSCIENS (RCUS)
NYSE
$18.79+$0.12 (+0.64%)
Price as of Nov 11, 2026 7:30 PM EST- $2.7BMarket Cap
- -7.98%1-Year Change
- BiotechnologyIndustry
ARCUS BIOSCIENS (RCUS)
$18.79+$0.12 (+0.64%)
RCUS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.67 | ||
Change | -$0.28 (-1.48%) | ||
Open | $19.02 | ||
High | $19.27 | ||
Low | $18.30 | ||
Previous Close | $18.95 | ||
Volume | 1,152,276 | ||
30-Day Average Volume | 2,566,125 | ||
1-Week Change | -1.27% | ||
1-Month Change | -23.51% | ||
1-Year Change | -7.98% | ||
3-Year Change | 37.89% | ||
5-Year Change | -52.08% | ||
Fundamentals | |||
Shares Outstanding | 144.0M | ||
Total Assets | $818.0M | ||
Market Cap | $2.7B | ||
Enterprise Value | $2.6B | ||
Period: QTR TTM FY | |||
Revenue | $5.0M | ||
Net Income | -$128.0M | ||
Free Cash Flow | -$88.0M | ||
EBIT | -$125.0M | ||
EBITDA | -$123.0M | ||
Net Working Capital | $465.0M | ||
EPS | -$1.00 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | 528 | ||
P/B | 8 | ||
P/E | -19 | ||
PEG | 0 | ||
Price/Free Cash Flow | -31 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue